Buxton helmsley calls for senate hearing on well-documented evident clinical data fraud at assertio

New york--(business wire)--the buxton helmsley group, inc. (together with certain of its affiliates, “bhg” or “we”), a new york city-based investment fund manager that recently inverted its long equity position into that of a short interest in the publicly traded securities of assertio holdings, inc. (“assertio” or the “company”) (nasdaq: asrt), today called upon the senate committee on health, education, labor & pensions (the “committee”) to investigate the evident product-related fraud at.
ASRT Ratings Summary
ASRT Quant Ranking